The effectiveness and sustainability of health outcomes from a holistic digital weight-loss service with concomitant initiation of tirzepatide: A pragmatic randomized controlled trial in the UK.
全方位數位減重服務結合 tirzepatide 啟動的健康結果有效性與可持續性:英國的一項務實隨機對照試驗。
Diabetes Obes Metab 2024-09-03
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.
體重變化與糖尿病患者在 tirzepatide 治療中的血糖控制關係:SURPASS 臨床試驗計畫的事後評估。
Diabetes Obes Metab 2023-08-03
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Tirzepatide每週一次治療第2型糖尿病患者肥胖的研究(SURMOUNT-2):一項雙盲、隨機、多中心、安慰劑對照的3期試驗。
Lancet 2023-12-18
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.
超重或肥胖成人在密集生活方式干預後使用 Tirzepatide:SURMOUNT-3 第3期試驗。
Nat Med 2024-03-22
In adults with BMI ≥27 kg/m<sup>2</sup> and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk.
在成人中,若BMI ≥27 kg/m<sup>2</sup>且患有第二型糖尿病,將 tirzepatide 添加至生活方式干預中可增加 72 週的體重減輕。
Ann Intern Med 2023-12-18
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
肥胖成人持續使用 Tirzepatide 維持體重減輕:SURMOUNT-4 隨機臨床試驗。
JAMA 2024-01-09
A Remotely Delivered, Semaglutide-Supported Specialist Weight Management Program: Preliminary Findings From a Retrospective Service Evaluation.
一項遠程提供、以塞麥格魯泰支持的專科體重管理計畫:來自回顧性服務評估的初步發現。
JMIR Form Res 2024-01-14
Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials.
Tirzepatide作為治療肥胖的新型有效且安全策略:隨機對照試驗的系統性回顧和荟萃分析。
Front Public Health 2024-04-28
Effectiveness of a hybrid approach in integrating GLP-1 agonists and lifestyle guidance for obesity and pre-diabetes management: RWE retrospective study.
GLP-1激動劑與生活方式指導在肥胖與糖尿病前期管理中的混合方法有效性:RWE回顧性研究。
Metabol Open 2024-05-04
Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial.
Tirzepatide用於中國肥胖成年人減重:SURMOUNT-CN隨機臨床試驗。
JAMA 2024-05-31
Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus.
在真實世界中評估 tirzepatide 對 2 型糖尿病患者的影響。
Diabetes Obes Metab 2024-09-09